{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:32:10Z","timestamp":1791595930336,"version":"4.3.4"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Despite limited data, international guidelines recommend the use of intravenous immunoglobulin (IVIg) in neonates with rhesus hemolytic disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>We tested whether prophylactic use of IVIg reduces the need for exchange transfusions in neonates with rhesus hemolytic disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DESIGN AND SETTING:<\/jats:title>\n                  <jats:p>We performed a randomized, double-blind, placebo-controlled trial in neonates with rhesus hemolytic disease. After stratification for treatment with intrauterine transfusion, neonates were randomly assigned for IVIg (0.75 g\/kg) or placebo (5% glucose). The primary outcome was the rate of exchange transfusions. Secondary outcomes were duration of phototherapy, maximum bilirubin levels, and the need of top-up red-cell transfusions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Eighty infants were included in the study, 53 of whom (66%) were treated with intrauterine transfusion(s). There was no difference in the rate of exchange transfusions between the IVIg and placebo groups (7 of 41 [17%] vs 6 of 39 [15%]; P = .99) and in the number of exchange transfusions per patient (median [range]: 0 [0\u20132] vs 0 [0\u20132]; P = .90) or in duration of phototherapy (4.7 [1.8] vs 5.1 [2.1] days; P = .34), maximum bilirubin levels (14.8 [4.7] vs 14.1 [4.9] mg\/dL; P = .52), and proportion of neonates who required top-up red-cell transfusions (34 of 41 [83%] vs 34 of 39 [87%]; P = .76).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Prophylactic IVIg does not reduce the need for exchange transfusion or the rates of other adverse neonatal outcomes. Our findings do not support the use of IVIg in neonates with rhesus hemolytic disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2010-3242","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T04:06:20Z","timestamp":1300766780000},"page":"680-686","source":"Crossref","is-referenced-by-count":72,"title":["Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial"],"prefix":"10.1542","volume":"127","author":[{"given":"Vivianne E. H. J.","family":"Smits-Wintjens","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J.","family":"Walther","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam E. A.","family":"Rath","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene T. M.","family":"Lindenburg","sequence":"additional","affiliation":[{"name":"Division of Fetal Medicine, Department of Obstetrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan B.","family":"te Pas","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Sanquin Blood Supply Foundation, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Oepkes","sequence":"additional","affiliation":[{"name":"Division of Fetal Medicine, Department of Obstetrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Brand","sequence":"additional","affiliation":[{"name":"Sanquin Blood Bank, Southwest Region and Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lopriore","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"issue":"4","key":"2021121007042850700_B1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.siny.2008.02.005","article-title":"Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome","volume":"13","author":"Smits-Wintjens","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2 pt 2","key":"2021121007042850700_B2","first-page":"417","article-title":"Morbidity and mortality associated with exchange transfusion","volume":"75","author":"Keenan","year":"1985","journal-title":"Pediatrics"},{"issue":"5","key":"2021121007042850700_B3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jpeds.2004.01.054","article-title":"Adverse events associated with neonatal exchange transfusion in the 1990s","volume":"144","author":"Patra","year":"2004","journal-title":"J Pediatr"},{"issue":"5","key":"2021121007042850700_B4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.99.5.e7","article-title":"Adverse events associated with exchange transfusion in healthy and ill newborns","volume":"99","author":"Jackson","year":"1997","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007042850700_B5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/peds.2006-2910","article-title":"A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality","volume":"120","author":"Steiner","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"2021121007042850700_B6","first-page":"CD004592","article-title":"Single versus double volume exchange transfusion in jaundiced newborn infants","author":"Thayyil","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021121007042850700_B7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1651-2227.1985.tb10984.x","article-title":"Exchange transfusion with fresh heparinized blood is a safe procedure: experiences from 1 069 newborns","volume":"74","author":"Hovi","year":"1985","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"2021121007042850700_B8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007042850700_B9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1423-0410.2008.01105.x","article-title":"Neonatal transfusions","volume":"96","author":"New","year":"2009","journal-title":"Vox Sang"},{"issue":"1","key":"2021121007042850700_B10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(05)82551-X","article-title":"High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease","volume":"121","author":"Rubo","year":"1992","journal-title":"J Pediatr"},{"issue":"1","key":"2021121007042850700_B11","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021121007042850700_B12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1651-2227.1999.tb01085.x","article-title":"High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice","volume":"88","author":"Alpay","year":"1999","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021121007042850700_B13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/030006059502300406","article-title":"High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease","volume":"23","author":"Dag\u0306og\u0306lu","year":"1995","journal-title":"J Int Med Res"},{"issue":"3","key":"2021121007042850700_B14","first-page":"CD003313","article-title":"Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates","author":"Alcock","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2021121007042850700_B15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1067\/mob.2001.112970","article-title":"Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization","volume":"184","author":"Oepkes","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121007042850700_B16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPI-2010-0251","article-title":"Bacillus cereus cerebral abscesses in a term neonate with rhesus hemolytic disease treated with exchange transfusion","volume":"5","author":"Smits-Wintjens","year":"2010","journal-title":"J Pediatr Inf Dis"},{"issue":"12","key":"2021121007042850700_B17","first-page":"1827","article-title":"Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn","volume":"27","author":"Nasseri","year":"2006","journal-title":"Saudi Med J"},{"issue":"1","key":"2021121007042850700_B18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/tropej\/47.1.50","article-title":"Multiple dose IVIg treatment in neonatal immune hemolytic jaundice","volume":"47","author":"Tanyer","year":"2001","journal-title":"J Trop Pediatr"},{"issue":"6","key":"2021121007042850700_B19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/jpme.1995.23.6.443","article-title":"Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease","volume":"23","author":"Voto","year":"1995","journal-title":"J Perinat Med"},{"issue":"3","key":"2021121007042850700_B20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000097661","article-title":"Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease","volume":"63","author":"Kriplani","year":"2007","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"2021121007042850700_B21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/adc.2009.159004","article-title":"Toward evidence based medicine for paediatricians: is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates","volume":"94","author":"Walsh","year":"2009","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021121007042850700_B22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000093204","article-title":"Intravenous immunoglobulin: striving for appropriate use","volume":"140","author":"Kumar","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"2021121007042850700_B23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/jmf.16.3.163.166","article-title":"Intravenous immunoglobulin G (IVIg) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn","volume":"16","author":"Miqdad","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2021121007042850700_B24","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1136\/adc.2005.076794","article-title":"Haemolytic disease of the newborn","volume":"92","author":"Murray","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2021121007042850700_B25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.siny.2007.06.007","article-title":"Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia","volume":"12","author":"Oepkes","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7","key":"2021121007042850700_B26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.1997.tb12026.x","article-title":"The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal","volume":"104","author":"Egberts","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"2021121007042850700_B27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajog.2007.05.030","article-title":"Pediatric outcome in rhesus hemolytic disease treated with and without intrauterine transfusion","volume":"198","author":"De Boer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2021121007042850700_B28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1423-0410.2010.01307.x","article-title":"Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions","volume":"99","author":"Rath","year":"2010","journal-title":"Vox Sang"},{"key":"2021121007042850700_B29","article-title":"High-dose intravenous immunoglobulin therapy for hyperbilirubinemia due to Rh hemolytic disease: a randomized clinical trial","author":"Santos"},{"issue":"1","key":"2021121007042850700_B30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1542\/peds.2009-0676","article-title":"Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease","volume":"125","author":"Figueras-Aloy","year":"2010","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/4\/680\/1055950\/zpe00411000680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/4\/680\/1055950\/zpe00411000680.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T16:24:39Z","timestamp":1639153479000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/4\/680\/65098\/Intravenous-Immunoglobulin-in-Neonates-With-Rhesus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,1]]},"published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-3242","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}